J. Safra Sarasin Holding AG Reduces Stock Position in Agilent Technologies, Inc. $A

Key Points

• J. Safra Sarasin Holding AG has reduced its stake in Agilent Technologies by 10.3%, now holding 223,574 shares valued at approximately $26.38 million.
• Agilent Technologies reported a quarterly earnings per share of $1.37, matching analysts' expectations, with revenue up 10.1% year-over-year.
• The company just declared a quarterly dividend of $0.248 per share, reflecting a 0.7% dividend yield on an annualized basis.

J. Safra Sarasin Holding AG trimmed its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 10.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 223,574 shares of the medical research company's stock after selling 25,720 shares during the period. J. Safra Sarasin Holding AG owned about 0.08% of Agilent Technologies worth $26,384,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Generation Investment Management LLP raised its position in Agilent Technologies by 19.8% during the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock worth $582,976,000 after acquiring an additional 824,243 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company's stock worth $448,748,000 after purchasing an additional 604,124 shares during the last quarter. Mackenzie Financial Corp grew its holdings in shares of Agilent Technologies by 141.5% during the first quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company's stock worth $109,481,000 after buying an additional 548,344 shares in the last quarter. Woodline Partners LP lifted its stake in shares of Agilent Technologies by 681.6% during the first quarter. Woodline Partners LP now owns 522,073 shares of the medical research company's stock valued at $61,072,000 after buying an additional 455,276 shares during the period. Finally, Parnassus Investments LLC grew its stake in Agilent Technologies by 38.3% in the 1st quarter. Parnassus Investments LLC now owns 1,577,999 shares of the medical research company's stock worth $184,594,000 after acquiring an additional 437,242 shares during the period.

Agilent Technologies Stock Up 8.1%

Shares of NYSE A opened at $138.75 on Thursday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The stock's 50-day simple moving average is $122.00 and its 200-day simple moving average is $116.17. The firm has a market cap of $39.34 billion, a price-to-earnings ratio of 32.57, a PEG ratio of 4.19 and a beta of 1.26.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts' consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the firm earned $1.32 EPS. Agilent Technologies's quarterly revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies's dividend payout ratio (DPR) is presently 23.24%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Robert W. Baird lifted their price objective on Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a research report on Thursday, August 28th. Evercore ISI decreased their target price on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a research report on Thursday, August 28th. Barclays reaffirmed an "equal weight" rating and set a $125.00 price target on shares of Agilent Technologies in a research report on Friday, August 29th. Wall Street Zen cut shares of Agilent Technologies from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Finally, Wells Fargo & Company increased their target price on Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a research report on Monday, September 15th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $140.08.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.